
    
      This is a randomized, cumulative dose, open-label, 2-period crossover, multi-center study to
      assess the safety, efficacy, PK, and extrapulmonary pharmacodynamics (PD) of cumulative doses
      of Albuterol Sulfate Pressurized Inhalation Suspension (hereafter referred to as AS MDI)
      compared to cumulative doses of ProventilÂ® hydrofluoroalkane (HFA; hereafter referred to as
      Proventil) as an active control in subjects with mild to moderate asthma.
    
  